Nat Gas Is Going to $5
Health Care: Drugs
Spectrum Pharmaceuticals Inc (SPPI: NASDAQ)
$8.43 0.30 | 3.69%
05/22/13 - 04:00 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 267.71M | 192.96M | 74.11M | 38.02M |
| Cost of Sales | 55.51M | 44.21M | 28.95M | 16.81M |
| Gross Operating Profit | 212.20M | 148.76M | 45.16M | 21.22M |
| Selling, General, and Administrative Expenses | 91.96M | 72.55M | 48.55M | 33.61M |
| Research & Development | 42.54M | 27.72M | 57.30M | 21.06M |
| Operating Income before D & A (EBITDA) | 77.69M | 48.48M | -60.69M | -33.45M |
| Depreciation & Amortization | -2.13M | -6.65M | -7.79M | -4.94M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income - Net | -844.00K | -2.91M | 4.01M | 7.90M |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | 78.98M | 52.22M | -48.89M | -20.61M |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Pre-Tax Income | 78.98M | 52.22M | -48.89M | -20.61M |
| Income Taxes | -15.56M | 3.70M | -43.00K | -421.00K |
| Minority Interest | 0.00 | 0.00 | 0.00 | -1.15M |
| Net Income From Continuing Operations | 94.54M | 48.52M | -48.84M | -19.05M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | 94.54M | 48.52M | -48.84M | -19.05M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | 94.54M | 48.52M | -48.84M | -19.05M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
94.54M | 48.52M | -48.84M | -19.05M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | 94.54M | 48.52M | -48.84M | -19.05M |
| Basic EPS from Continuing Ops. | 1.61 | 0.91 | -0.99 | -0.48 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | 1.61 | 0.91 | -0.99 | -0.48 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | 1.61 | 0.91 | -0.99 | -0.48 |
| Basic Normalized Net Income/Share | 1.61 | 0.91 | -0.99 | -0.48 |
| EPS fr Continuing Ops. | 1.46 | 0.84 | -0.99 | -0.48 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | 1.46 | 0.84 | -0.99 | -0.48 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | 1.46 | 0.84 | -0.99 | -0.48 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
1.46 | 0.84 | -0.99 | -0.48 |
| Dividends Paid per Share | 0.15 | 0.00 | 0.00 | 0.00 |
Portfolios with SPPI
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- ContributorBreakout Stocks Of The Week...
- ContributorHot Biotech Stocks Traded b...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- UserStock/ETF
- ContributorHeavily Shorted Market Lead...
Latest SPPI Headlines from TheStreet
- Biotech Stock Mailbag: Vical, Sangamo, Spectrum Pharma 05.17.13 | 07:05 am
- The 5 Dumbest Things on Wall Street This Week: May 17 05.17.13 | 07:05 am
- 5 Dumbest Things on Wall Street
05.17.13 | 05:05 am - SEC Is Investigating Spectrum Pharma 05.13.13 | 07:05 am
- 5 Stocks Poised to Break Out 05.10.13 | 02:05 pm
- Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- 5 Dumbest Things 'April Fools' Quiz 03.29.13 | 07:03 am
- TheStreet Ratings Top 10 Rating Changes 03.25.13 | 01:03 pm
- Spectrum Pharmaceuticals Inc Stock Downgraded (SPPI) 03.20.13 | 05:03 am
- Healthcare Sector: High Quality Stocks At A Great Value 03.18.13 | 02:03 pm
Press Releases for SPPI
- Abraham, Fruchter & Twersky, LLP Announces That A Class Action Lawsuit Has Been Filed Against Spectrum Pharmaceuticals, Inc. - Business Wire 03.22.13 | 12:03 pm
- Lifshitz Law Firm Announces Investigation Of Navistar International Corporation, Spectrum Pharmaceuticals, Inc., And Tech Data Corporation - PR Newswire 03.22.13 | 11:03 am
- Hagens Berman Notifies Spectrum Pharmaceuticals Investors Of Pending Class-Action Lawsuit And May 13, 2013, Lead Plaintiff Deadline - Business Wire 03.22.13 | 09:03 am
- Spectrum Pharmaceuticals, Inc. Sued By Shareholders - PR Newswire 03.21.13 | 07:03 pm
- Spectrum Pharmaceuticals Shareholder Alert: Briscoe Law And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors - Business Wire 03.21.13 | 10:03 am
- Spectrum Pharmaceuticals Appoints Lee F. Allen, M.D., Ph.D., Industry Veteran, As Chief Medical Officer - Business Wire 03.18.13 | 07:03 am
- Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Spectrum Pharmaceuticals, Inc. - Business Wire 03.15.13 | 04:03 pm
- Ryan & Maniskas, LLP Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. - PR Newswire 03.15.13 | 03:03 pm
- Spectrum Pharmaceuticals To Present Corporate Update At The 25th Annual ROTH Conference In Laguna Niguel On March 20th - Business Wire 03.15.13 | 07:03 am
- Spectrum Pharmaceuticals Gains Rights To Pivotal-Stage Captisol-Enabled® Melphalan - Business Wire 03.14.13 | 07:03 am
Partner Headlines for SPPI
- A Journey To Add Biotech To The Portfolio - Seeking Alpha 05.18.13 | 02:05 am
- How Dangerous are Five of the Most Heavily Shorted Small Cap Stocks? - Benzinga 05.17.13 | 04:05 pm
- This Drug Market Could Expand 80-Fold by 2020 - NASDAQ 10.17.12 | 01:10 pm
- SPPI a Step Closer to Allos - Analyst Blog - NASDAQ 08.31.12 | 09:08 pm
- Spectrum Extends Allos Buyout Offer - Analyst Blog - NASDAQ 08.21.12 | 02:08 pm
- Notable Small-Cap Insider Sells Filed On August 16 - Seeking Alpha 08.17.12 | 09:08 am
- Reassessing & Continuing To Monitor Portfolios For Success - Seeking Alpha 07.30.12 | 09:07 am
- Rituxan And Its Biosimilar Competitors - Seeking Alpha 07.30.12 | 09:07 am
- Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics - Benzinga 07.20.12 | 06:07 pm
- Pluristem Therapeutics' Answer To Big Pharma's Question: What Do We Do Now? - Seeking Alpha 07.18.12 | 09:07 am
